International Diabetes Federation-Diabetes and Ramadan Alliance (IDF-DAR) Fasting Risk Assessment

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
risk score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–3
  • Moderate Risk3.5–6
  • High Risk6.5–20
Direct Clinical Answer

The International Diabetes Federation-Diabetes and Ramadan Alliance (IDF-DAR) Fasting Risk Assessment calculates evaluating glycemic control, metabolic decompensation severity, and long-term endocrine risks. Key inputs include diabetes type. Scores guide titrating insulin infusion protocols, managing fluid-electrolyte resuscitation, and long-term risk reduction. Routine clinical application promotes standardized evidence-based patient management.

Clinical Guidelines & Evidence

Stratifies risk of fasting during Ramadan in diabetic patients using validated clinical parameters. The IDF-DAR tool provides evidence-based guidance for healthcare providers and patients to make informed decisions about the safety of fasting during Ramadan based on diabetes type, glycemic control, complications, and other risk factors.

Clinical Indication

The International Diabetes Federation-Diabetes and Ramadan Alliance (IDF-DAR) Fasting Risk Assessment is indicated for bedside clinical practice to support Stratifies risk of fasting during Ramadan in diabetic patients using validated clinical parameters. The IDF-DAR tool provides evidence-based guidance for healthcare providers and patients to make informed decisions about the safety of fasting during Ramadan based on diabetes type, glycemic control, complications, and other risk factors.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with diabetes mellitus, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state, thyroid storm, or adrenal crisis. Clinical application is indicated across Endocrinology clinics, inpatient metabolic services, and acute diabetes care units.

Limitations & Contraindications

Severe hyperglycemia lowers measured serum sodium; corrected sodium equations must guide intravenous fluid selection.

Clinical Pearls & Action Plan

Serial monitoring of serum electrolytes, potassium kinetics, venous pH, and anion gap is mandatory during acute metabolic crisis management.

Formula & Variables:

Risk Score = Diabetes Type + Years Since Diagnosis + Hypoglycemia Score + HbA1c Score + Treatment Score + Monitoring Score + Complication Scores + Social Factors

Input Parameters

NameTypeRequiredDescription
diabetes_typestringYesType of diabetes mellitus. Type 1 diabetes carries higher baseline fasting risk due to insulin dependence and greater glycemic variability
years_since_diagnosisstringYesDuration of diabetes diagnosis. Longer duration associated with increased risk of complications and glucose variability(years)
hypoglycemia_frequencystringYesFrequency and severity of hypoglycemic episodes. Recent severe hypoglycemia or hypoglycemia unawareness significantly increases fasting risk
hba1c_levelstringYesGlycemic control measured by HbA1c. Poor control (>9%) indicates higher risk of acute complications during fasting(%)
treatment_typestringYesCurrent diabetes treatment regimen. Insulin therapy and certain sulfonylureas increase hypoglycemia risk during fasting
self_monitoring_frequencystringYesBlood glucose self-monitoring frequency. Regular monitoring enables safer fasting through early detection of glucose abnormalities
acute_complicationsstringYesHistory of acute diabetic complications including diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS) within the past 3 months
macrovascular_diseasestringYesPresence of macrovascular complications including coronary artery disease, cerebrovascular disease, or peripheral arterial disease
renal_complicationsstringYesDiabetic nephropathy or chronic kidney disease stage 4-5 (eGFR <30 mL/min/1.73m²)
pregnancy_statusstringYesPregnancy or breastfeeding status. Pregnant and breastfeeding women with diabetes are generally advised against fasting
frailty_cognitive_functionstringYesFrailty or cognitive impairment that may impair ability to recognize or respond to hypoglycemia symptoms
physical_laborstringYesOccupation involving intense physical labor or activity that increases metabolic demands and hypoglycemia risk during fasting
previous_ramadan_experiencestringYesExperience with previous Ramadan fasting. Prior successful fasting may indicate better tolerance and risk management
fasting_hoursstringYesDuration of daily fasting hours based on geographic location and season. Longer fasting periods increase dehydration and hypoglycemia risk(hours)

Score Interpretation & Guidance

RangeStageDescription
0–3Low RiskFasting probably safe
3.5–6Moderate RiskFasting safety uncertain
6.5–20High RiskFasting probably unsafe

Evidence-Based References (EBM)

  • Hassanein M, Sahay BK, Hafidh K, Djaballah K, Li H, Rahim MA, et al. Diabetes and Ramadan: Practical guidelines 2021. Diabetes Res Clin Pract. 2022 Mar;185:109185. doi: 10.1016/j.diabres.2021.109185.DOI: 10.1016/j.diabres.2021.109185
  • Ibrahim M, Al Magd MA, Annabi FA, Assaad-Khalil S, Ba-Essa EM, Fahdil I, et al. Recommendations for management of diabetes during Ramadan: update 2020, applying evidence from a decade of research. BMJ Open Diabetes Res Care. 2020 May;8(1):e001248. doi: 10.1136/bmjdrc-2020-001248.DOI: 10.1136/bmjdrc-2020-001248
  • Alam F, Oubari S, Ahmad J, Eba-Alkhayri A, Almadani A, Babineaux S, et al. Validity of the International Diabetes Federation risk stratification score of Ramadan fasting in individuals with diabetes mellitus. Saudi Med J. 2024 Jan;45(1):86-92. doi: 10.15537/smj.2024.45.1.20230497.DOI: 10.15537/smj.2024.45.1.20230497

Related calculators